[
  {
    "report_key": "2026:q2",
    "period_label": "2026 Q2",
    "date": "2026-07-16",
    "title": "Kvartalsrapport Q2 2026",
    "original_title": "Delårsrapport för andra kvartalet 2026: Betydande tillväxt med viktiga framsteg i pipeline",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b365e03256abb7257729b91f1fdb739b5&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2026,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2026",
        "title": "Kvartalsrapport Q2 2026",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a2d4ce634319b47e67508fcb6cb34241c",
        "date": "2026-07-16",
        "period": "2026-q2",
        "form_type": "interim-report",
        "report_key": "2026:q2",
        "filename": "07159325.pdf",
        "text_chars": 95367,
        "sha256": "a34cda4a5b706a0431497a4779e306b88014ff959e91108f7004b7bc5bf7176f",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026/part-001.html",
            "chars": 95367
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2026:q1",
    "period_label": "2026 Q1",
    "date": "2026-04-28",
    "title": "Kvartalsrapport Q1 2026",
    "original_title": "Delårsrapport för första kvartalet 2026: Stark leverans och viktiga framsteg i pipeline",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bed68bf42c6b0537709ebdf78beb3fa2b&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2026,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
        "title": "Kvartalsrapport Q1 2026",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a8a7a6601c2707c4b51e02e890746db2f",
        "date": "2026-04-28",
        "period": "2026-q1",
        "form_type": "interim-report",
        "report_key": "2026:q1",
        "filename": "04274767.pdf",
        "text_chars": 81834,
        "sha256": "b17b8a3e88ae51823e04f53e569bec75bad8751bc3b6465fb285cb18dccd5eb6",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
            "chars": 81834
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:annual",
    "period_label": "2025 Årsredovisning",
    "date": "2026-03-31",
    "title": "Årsredovisning 2025",
    "original_title": "Sobi publicerar sin års- och hållbarhetsredovisning för 2025",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bbee04901d0f6d47c2d106193ba757199&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2025,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2025",
        "title": "Årsredovisning 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a803413b852d7619e00ffe60a724e1771",
        "date": "2026-03-31",
        "period": "2025-annual",
        "form_type": "annual-report",
        "report_key": "2025:annual",
        "filename": "03260875.pdf",
        "text_chars": 803680,
        "sha256": "fd8fcf28461ff21c27a6d013e4c251d1b92a88ace95916316406226328217ab2",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
            "chars": 177160
          },
          {
            "number": 2,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
            "chars": 178827
          },
          {
            "number": 3,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-003.html",
            "chars": 174083
          },
          {
            "number": 4,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-004.html",
            "chars": 179401
          },
          {
            "number": 5,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-005.html",
            "chars": 94201
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q4",
    "period_label": "2025 Q4",
    "date": "2026-02-05",
    "title": "Kvartalsrapport Q4 2025",
    "original_title": "Sobi publicerar delårsrapport för fjärde kvartalet och bokslutskommuniké för 2025: Året avslutas med betydande tillväxt och strategiska framsteg",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=be43ea8f84c7f543211d60ffb0ee38389&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2025,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
        "title": "Kvartalsrapport Q4 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a2dc581a992b369dca4b24f3a09c91ce2",
        "date": "2026-02-05",
        "period": "2025-q4",
        "form_type": "year-end-report",
        "report_key": "2025:q4",
        "filename": "02046223.pdf",
        "text_chars": 87369,
        "sha256": "a2cc733202c349e0f23a0a66ad6511d755bc8758dc925ee45b1992f67c565298",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
            "chars": 87369
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q3",
    "period_label": "2025 Q3",
    "date": "2025-10-20",
    "title": "Kvartalsrapport Q3 2025",
    "original_title": "Sobi publicerar delårsrapport för tredje kvartalet 2025: Accelererad tillväxt och momentum i portföljen",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b71dc6f1b63155386dcbeaa46922c9138&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
        "title": "Kvartalsrapport Q3 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/ad0ebc4a6d6b69a0d790480924eecfcce",
        "date": "2025-10-20",
        "period": "2025-q3",
        "form_type": "interim-report",
        "report_key": "2025:q3",
        "filename": "10195737.pdf",
        "text_chars": 95082,
        "sha256": "36fffff42260f19d0513ca423002caaf2a7bd69d24200999387039e4c8e89fb0",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
            "chars": 95082
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q2",
    "period_label": "2025 Q2",
    "date": "2025-07-16",
    "title": "Kvartalsrapport Q2 2025",
    "original_title": "Sobi publicerar delårsrapport för andra kvartalet 2025: Fortsatt starkt momentum i portfölj och pipeline",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b0cf7fdf0365e2db9afdb4c2b3805d450&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
        "title": "Kvartalsrapport Q2 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/abaad6a191845e90e57292d3057ecd186",
        "date": "2025-07-16",
        "period": "2025-q2",
        "form_type": "interim-report",
        "report_key": "2025:q2",
        "filename": "07159972.pdf",
        "text_chars": 85283,
        "sha256": "4af6df9a017876eecf7a09b68e407080a211b7644ca383f2d0e87921598bd92a",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
            "chars": 85283
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q1",
    "period_label": "2025 Q1",
    "date": "2025-04-29",
    "title": "Kvartalsrapport Q1 2025",
    "original_title": "Sobi publicerar delårsrapport för första kvartalet 2025: Portföljen fortsätter att leverera",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b2ced551b8b75d310c83a7ba33d19a3cc&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
        "title": "Kvartalsrapport Q1 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a845fd2722e07b9aaa05e3d2cfbc26000",
        "date": "2025-04-29",
        "period": "2025-q1",
        "form_type": "interim-report",
        "report_key": "2025:q1",
        "filename": "04283614.pdf",
        "text_chars": 71886,
        "sha256": "a1cfb110b5623431908cb455ccdfc00c62ef13dbaa377bfe543b42a76805f04b",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
            "chars": 71886
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:annual",
    "period_label": "2024 Årsredovisning",
    "date": "2025-03-31",
    "title": "Årsredovisning 2024",
    "original_title": "Sobi publicerar sin års- och hållbarhetsredovisning för 2024",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b6295957feca0dfeda661776c554f69ad&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2024,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2024",
        "title": "Årsredovisning 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a0959a7d05a6fcf8fe7bdfb639249c3e8",
        "date": "2025-03-31",
        "period": "2024-annual",
        "form_type": "annual-report",
        "report_key": "2024:annual",
        "filename": "03277258.pdf",
        "text_chars": 712072,
        "sha256": "e58e5e6fcae3dbe82a8cd98cd91edb16a2c34d325a055692239bceaec4aa5447",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
            "chars": 179806
          },
          {
            "number": 2,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
            "chars": 177327
          },
          {
            "number": 3,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-003.html",
            "chars": 176398
          },
          {
            "number": 4,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-004.html",
            "chars": 178535
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q4",
    "period_label": "2024 Q4",
    "date": "2025-02-05",
    "title": "Kvartalsrapport Q4 2024",
    "original_title": "Sobi publicerar delårsrapport för fjärde kvartalet och bokslutskommuniké för 2024: Starkt avslut på ett framgångsrikt år",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b908a0f33e1d726c33c427edfe8364e84&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2024,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
        "title": "Kvartalsrapport Q4 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a023e6a80152f1c92f009fd9ee16a0933",
        "date": "2025-02-05",
        "period": "2024-q4",
        "form_type": "year-end-report",
        "report_key": "2024:q4",
        "filename": "02041851.pdf",
        "text_chars": 82419,
        "sha256": "f6caa376e1fd958c217d3fb05b7e9aeaac3999cfadcbba3c24142f35df417f69",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
            "chars": 82419
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q3",
    "period_label": "2024 Q3",
    "date": "2024-10-24",
    "title": "Kvartalsrapport Q3 2024",
    "original_title": "Sobi publicerar delårsrapport för tredje kvartalet 2024: Stark tillväxt och väsentliga framsteg i pipeline",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b38af79e7e83c8ee2438b1d66ea802a36&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
        "title": "Kvartalsrapport Q3 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a663c36aa30977493cbca55d44f3473e8",
        "date": "2024-10-24",
        "period": "2024-q3",
        "form_type": "interim-report",
        "report_key": "2024:q3",
        "filename": "10236498.pdf",
        "text_chars": 83194,
        "sha256": "5ba80e24f38d110e6f69c5f05792486b46fc677a43532d649903d6d1dc6212a6",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
            "chars": 83194
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q2",
    "period_label": "2024 Q2",
    "date": "2024-07-16",
    "title": "Kvartalsrapport Q2 2024",
    "original_title": "Sobi publicerar delårsrapport för andra kvartalet 2024: Stark leverans driven av robust utveckling i portföljen",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b3ca6c22d01335bbc3ad7becda29f2f63&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
        "title": "Kvartalsrapport Q2 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a30f3433f133728239646c72979408bc8",
        "date": "2024-07-16",
        "period": "2024-q2",
        "form_type": "interim-report",
        "report_key": "2024:q2",
        "filename": "07155900.pdf",
        "text_chars": 79272,
        "sha256": "2beb780fc696e0cdc36ad6c847af8ea887fe5173fc37488471dcb4866a564363",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
            "chars": 79272
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q1",
    "period_label": "2024 Q1",
    "date": "2024-04-25",
    "title": "Kvartalsrapport Q1 2024",
    "original_title": "Sobi publicerar delårsrapport för första kvartalet 2024: Stark försäljning speglar styrkan i portföljen",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bf19a885a6ffb3ee929892e3dd31a5614&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
        "title": "Kvartalsrapport Q1 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a859af69b59fde0bbeaea3f650018db9f",
        "date": "2024-04-25",
        "period": "2024-q1",
        "form_type": "interim-report",
        "report_key": "2024:q1",
        "filename": "04247488.pdf",
        "text_chars": 72854,
        "sha256": "93cce24ab1bc25e4919a1340756e72ba8c5e1d74aa66fce087ca8ff1982ac26b",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
            "chars": 72854
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:annual",
    "period_label": "2023 Årsredovisning",
    "date": "2024-04-02",
    "title": "Årsredovisning 2023",
    "original_title": "Sobi publicerar sin års- och hållbarhetsredovisning för 2023",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b674ba2f74fae1b353eb07c2629f99b0c&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2023,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2023",
        "title": "Årsredovisning 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a3a0129a40ccc4e88990e701eed9d58fb",
        "date": "2024-04-02",
        "period": "2023-annual",
        "form_type": "annual-report",
        "report_key": "2023:annual",
        "filename": "03273911.pdf",
        "text_chars": 610135,
        "sha256": "2e692ad7e8c497878cdca331763d72469c7bd11f6d110bdcf44968032bd28cb4",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
            "chars": 171277
          },
          {
            "number": 2,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
            "chars": 179719
          },
          {
            "number": 3,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-003.html",
            "chars": 175384
          },
          {
            "number": 4,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-004.html",
            "chars": 83749
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q4",
    "period_label": "2023 Q4",
    "date": "2024-02-08",
    "title": "Kvartalsrapport Q4 2023",
    "original_title": "Sobi publicerar delårsrapport för fjärde kvartalet och bokslutskommuniké för 2023: Stark intäktsutveckling och tillväxt in i 2024",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b82a48fcad5e4336da5c54b0ae1dd521d&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2023,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
        "title": "Kvartalsrapport Q4 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/adde0b322dea3c5b52faacfe607f60b9c",
        "date": "2024-02-08",
        "period": "2023-q4",
        "form_type": "year-end-report",
        "report_key": "2023:q4",
        "filename": "02073988.pdf",
        "text_chars": 80677,
        "sha256": "69fd59510737bbc9c3bfa404f2cf4c3af955915b786cbf5564668e7451ad055b",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
            "chars": 80677
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q3",
    "period_label": "2023 Q3",
    "date": "2023-10-30",
    "title": "Kvartalsrapport Q3 2023",
    "original_title": "Sobi publicerar delårsrapport för tredje kvartalet 2023: Stark försäljning och stabil leverans",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b92ac36d21ba1be39d3c190e77f91cad2&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
        "title": "Kvartalsrapport Q3 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a7c69cbef88bfba2017353bab0c4b272f",
        "date": "2023-10-30",
        "period": "2023-q3",
        "form_type": "interim-report",
        "report_key": "2023:q3",
        "filename": "10284167.pdf",
        "text_chars": 81081,
        "sha256": "dbf191c8acb11841235477fa308d2ff22f5521f309168824aede1b306863c4ae",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
            "chars": 81081
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q2",
    "period_label": "2023 Q2",
    "date": "2023-07-18",
    "title": "Kvartalsrapport Q2 2023",
    "original_title": "Sobi publicerar delårsrapport för andra kvartalet 2023: Tillväxt och utökad pipeline",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bcbbe240e554895c93760cb53d1624ffe&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
        "title": "Kvartalsrapport Q2 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/ad1ceec26e0bd18055c21d64818ce3a6b",
        "date": "2023-07-18",
        "period": "2023-q2",
        "form_type": "interim-report",
        "report_key": "2023:q2",
        "filename": "07174924.pdf",
        "text_chars": 84136,
        "sha256": "7234f04db1009d9a9039d6b0c0fc4820db51d777a11f09d99f2df0904ffde798",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
            "chars": 84136
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q1",
    "period_label": "2023 Q1",
    "date": "2023-04-27",
    "title": "Kvartalsrapport Q1 2023",
    "original_title": "Sobi publicerar delårsrapport för första kvartalet 2023: Fortsatt stabil utveckling",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=baecfed01956ab788b0df2c9c5dd1fc8f&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
        "title": "Kvartalsrapport Q1 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/aa660dc1176676aee312b120c11a1d606",
        "date": "2023-04-27",
        "period": "2023-q1",
        "form_type": "interim-report",
        "report_key": "2023:q1",
        "filename": "04267261.pdf",
        "text_chars": 69614,
        "sha256": "f3cc4e5143ede980a0eab03e39b37a19d68a2704e3634614ab759118d70f1bda",
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
            "chars": 69614
          }
        ]
      }
    ],
    "alternatives": []
  }
]